Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Mark Goines, a director of Life360, Inc. (LIF), sold 20,000 shares of the company's common stock on 08/22/2025 at a weighted average price of $86.87 per share (sales ranged $86.87–$86.93). After the sale and related transfers, the reporting person beneficially owns 71,809 shares, held indirectly through the Goines Wong Living Trust. The filing discloses that 55,537 directly held shares were transferred to that trust in a transaction exempt under Rule 16a-13, and that 2,866 restricted stock units remain contingent rights to receive shares upon vesting.
Life360, Inc. (LIF) Form 4 shows Russell John Burke, the company's Chief Financial Officer and a Director, reported a transaction dated 08/22/2025. The filing discloses a gift of 5,870 shares of common stock to a donor-advised fund; the shares were donated (code G(1)) at a price of $0 and the reporting person "retains no beneficial ownership or control" of the donated securities after the contribution.
The reporting person is shown as beneficially owning 190,548 shares following the transaction, which the filing notes includes 111,231 restricted stock units that convert to shares upon vesting. The form was signed by an attorney-in-fact on 08/26/2025.
Form 144 filed for Life360, Inc. (LIF): The filing notifies a proposed sale of 16,287 shares of common stock to be executed through Charles Schwab on 08/26/2025 on NASDAQ with an aggregate market value of $1,477,556.00. The seller previously acquired shares via equity awards on 08/19/2024 (11,100 shares), 03/27/2025 (1,541 shares), and 06/05/2025 (3,646 shares), all listed as equity compensation from the issuer. The filing also reports four completed sales by Russell John Burke in the past three months totaling 12,342 shares for gross proceeds of $820,333.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Life360, Inc. (LIF) Form 144 notice reports a proposed sale of 1,858 common shares through Fidelity Brokerage Services, with an aggregate market value of $167,220, scheduled approximately for 08/26/2025. The shares were acquired on 12/02/2024 upon restricted stock vesting and were granted as compensation. The filing lists multiple sales by the same person, Susan Stick, during the prior three months totaling 10,210 shares and gross proceeds of approximately $764,008.87 across dates from 05/27/2025 to 08/25/2025. The issuer has 77,548,651 shares outstanding per the form. The filer certifies no undisclosed material adverse information and attests to the truthfulness of the notice.
Life360, Inc. (LIF) filed a Form 144 reporting proposed sale of common stock by an insider. The notice lists 3,323 shares planned for sale through Fidelity Brokerage Services with an aggregate market value of $299,563.47, and an approximate sale date of 08/25/2025 on NASDAQ. The filing shows those shares were acquired in 2024 through restricted stock vesting as compensation (622 shares on 09/19/2024, 969 shares on 11/15/2024, and 1,732 shares on 12/02/2024). The filing also discloses historical sales by the same person, Susan Stick, totaling 6,387 shares sold across seven transactions in 2025, generating $419,445.40 in gross proceeds.
Life360, Inc. insider Lauren Antonoff filed a Form 144 to sell 4,546 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $409,140, and an intended sale date of 08/25/2025. The shares were acquired on 06/20/2024 via restricted stock vesting and were received as compensation. The filing reports total outstanding shares of 77,548,651. The notice also discloses four prior sales by the same person in the past three months totaling 32,446 shares for gross proceeds of $2,125,940.60.
Form 144 filed for Life360, Inc. (LIF) reporting a proposed sale of 500 common shares to be executed approximately on 08/25/2025 through Fidelity Brokerage Services. The shares were acquired on 09/19/2024 upon restricted stock vesting and were issued as compensation. The filing lists 77,548,651 shares outstanding for the issuer and an aggregate market value for the proposed sale of $45,000.00.
The filing also discloses prior sales by the same person during the past three months totaling 6,387 shares with gross proceeds of $419,445.40, consisting of multiple transactions between 05/27/2025 and 08/11/2025. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.
John Philip Coghlan, a director of Life360, Inc. (LIF), reported securities transactions on a Form 4. On 08/15/2025 he sold 10,000 shares of Life360 common stock at a weighted average price of $85.01 per share, with sale prices in the range of $85.00 to $85.10. After the reported transactions the filing shows the reporting person beneficially owns 67,604 shares indirectly held by the John Philip Coghlan 2025 Grantor Retained Annuity Trust and 12,500 shares indirectly held by the John Coghlan Living Trust. The filing also records 3,344 restricted stock units (described as contingent rights to receive common shares upon vesting). The Form 4 is signed by an attorney-in-fact on 08/22/2025.
Life360, Inc. (LIF) Form 144 notice reports a proposed sale of 20,000 common shares by a holder through Charles Schwab, with an aggregate market value of $1,734,400.00. The shares represent a small fraction of the company's 77,548,651 shares outstanding. The filer acquired the shares in a private placement on 10/24/2011 and paid via wired funds. The planned sale is approximately dated 08/22/2025 and the securities are listed on NASDAQ. The filer certifies no undisclosed material adverse information and no securities of the issuer were sold by the filer in the past three months.
Life360, Inc. (LIF) director James Synge reported multiple open-market dispositions of common stock equivalents tied to Australian CDIs between August 15 and August 18, 2025. The filings show sales of 24,919 and 81 common-stock-equivalent shares on August 15 at weighted average prices of $84.23 and $85.25 respectively, and a further 25,000 shares on August 18 at a weighted average price of $85.80, reflecting conversions from CDIs using a 1:3 ratio and AUD-to-USD exchange rates. After these transactions the reporting person directly held 194,754 common shares and indirectly held 3,966 shares through ICCA Labs, LLC, and the reported holdings include 2,810 unvested restricted stock units.